Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 106
Filtrer
1.
BMC Genomics ; 25(1): 637, 2024 Jun 26.
Article de Anglais | MEDLINE | ID: mdl-38926663

RÉSUMÉ

Dynamic metabolic reprogramming occurs at different stages of myogenesis and contributes to the fate determination of skeletal muscle satellite cells (MuSCs). Accumulating evidence suggests that mutations in myostatin (MSTN) have a vital role in regulating muscle energy metabolism. Here, we explored the metabolic reprogramming in MuSCs and myotube cells in MSTN and FGF5 dual-gene edited sheep models prepared previously, and also focused on the metabolic alterations during myogenic differentiation of MuSCs. Our study revealed that the pathways of nucleotide metabolism, pantothenate and CoA biosynthesis were weakened, while the unsaturated fatty acids biosynthesis were strengthened during myogenic differentiation of sheep MuSCs. The MSTN and FGF5 dual-gene editing mainly inhibited nucleotide metabolism and biosynthesis of unsaturated fatty acids in sheep MuSCs, reduced the number of lipid droplets in per satellite cell, and promoted the pentose phosphate pathway, and the interconversion of pentose and glucuronate. The MSTN and FGF5 dual-gene editing also resulted in the inhibition of nucleotide metabolism and TCA cycle pathway in differentiated myotube cells. The differential metabolites we identified can be characterized as biomarkers of different cellular states, and providing a new reference for MSTN and FGF5 dual-gene editing in regulation of muscle development. It may also provide a reference for the development of muscle regeneration drugs targeting biomarkers.


Sujet(s)
Facteur de croissance fibroblastique de type 5 , Édition de gène , Développement musculaire , Myostatine , Animaux , Myostatine/génétique , Myostatine/métabolisme , Développement musculaire/génétique , Ovis , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme , Différenciation cellulaire , Cellules satellites du muscle squelettique/métabolisme , Cellules satellites du muscle squelettique/cytologie , Fibres musculaires squelettiques/métabolisme , Fibres musculaires squelettiques/cytologie
2.
Cells ; 13(11)2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38891117

RÉSUMÉ

Fibroblast growth factor 5 (FGF5) plays key roles in promoting the transition from the anagen to catagen during the hair follicle cycle. The sheep serves as an excellent model for studying hair growth and is frequently utilized in various research processes related to human skin diseases. We used the CRISPR/Cas9 system to generate four FGF5-edited Dorper sheep and only low levels of FGF5 were detected in the edited sheep. The density of fine wool in GE sheep was markedly increased, and the proportion of fine wool with a diameter of 14.4-20.0 µm was significantly higher. The proliferation signal in the skin of gene-edited (GE) sheep was stronger than in wild-type (WT) sheep. FGF5 editing decreased cortisol concentration in the skin, further activated the activity of antioxidant enzymes such as Glutathione peroxidase (GSH-Px), and regulated the expression of Wnt signaling pathways containing Wnt agonists (Rspondins, Rspos) and antagonists (Notum) in hair regeneration. We suggest that FGF5 not only mediates the activation of antioxidant pathways by cortisol, which constitutes a highly coordinated microenvironment in hair follicle cells, but also influences key signals of the Wnt pathway to regulate secondary hair follicle (SHF) development. Overall, our findings here demonstrate that FGF5 plays a significant role in regulating SHF growth in sheep and potentially serves as a molecular marker of fine wool growth in sheep breeding.


Sujet(s)
Facteur de croissance fibroblastique de type 5 , Glutathione peroxidase , Follicule pileux , Voie de signalisation Wnt , Laine , Animaux , Facteur de croissance fibroblastique de type 5/métabolisme , Facteur de croissance fibroblastique de type 5/génétique , Ovis , Laine/métabolisme , Follicule pileux/métabolisme , Follicule pileux/croissance et développement , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , Édition de gène , Hydrocortisone/métabolisme , Prolifération cellulaire , Systèmes CRISPR-Cas/génétique
3.
Genes (Basel) ; 15(4)2024 03 26.
Article de Anglais | MEDLINE | ID: mdl-38674344

RÉSUMÉ

This study investigated the regulatory effect of alternative spliceosomes of the fibroblast growth factor 5 (FGF5) gene on hair follicle (HF) growth and development in rabbits. The FGF5 alternative spliceosomes (called FGF5-X1, FGF5-X2, FGF5-X3) were cloned. The overexpression vector and siRNA of spliceosomes were transfected into dermal papilla cells (DPCs) to analyze the regulatory effect on DPCs. The results revealed that FGF5-X2 and FGF5-X3 overexpression significantly decreased LEF1 mRNA expression (p < 0.01). FGF5-X1 overexpression significantly reduced CCND1 expression (p < 0.01). FGF5-X1 and FGF5-X2 possibly downregulated the expression level of FGF2 mRNA (p < 0.05), and FGF5-X3 significantly downregulated the expression level of FGF2 mRNA (p < 0.01). The FGF5 alternative spliceosomes significantly downregulated the BCL2 mRNA expression level in both cases (p < 0.01). FGF5-X1 and FGF5-X2 significantly increased TGFß mRNA expression (p < 0.01). All three FGF5 alternative spliceosomes inhibited DPC proliferation. In conclusion, the expression profile of HF growth and development-related genes can be regulated by FGF5 alternative spliceosomes, inhibiting the proliferation of DPCs and has an influence on the regulation of HF growth in rabbits. This study provides insights to further investigate the mechanism of HF development in rabbits via FGF5 regulation.


Sujet(s)
Facteur de croissance fibroblastique de type 5 , Follicule pileux , Animaux , Lapins , Follicule pileux/croissance et développement , Follicule pileux/métabolisme , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme , Prolifération cellulaire/génétique , Épissage alternatif
4.
J Cell Mol Med ; 27(23): 3706-3716, 2023 12.
Article de Anglais | MEDLINE | ID: mdl-37950418

RÉSUMÉ

Excessive productions of inflammatory cytokines and free radicals are involved in spinal cord injury (SCI). Fibroblast growth factor 5 (FGF5) is associated with inflammatory response and oxidative damage, and we herein intend to determine its function in SCI. Lentivirus was instilled to overexpress or knockdown FGF5 expression in mice. Compound C or H89 2HCl were used to suppress AMP-activated protein kinase (AMPK) or protein kinase A (PKA), respectively. FGF5 level was significantly decreased during SCI. FGF5 overexpression mitigated, while FGF5 silence further facilitated inflammatory response, oxidative damage and SCI. Mechanically, FGF5 activated AMPK to attenuate SCI in a cAMP/PKA-dependent manner, while inhibiting AMPK or PKA with pharmacological methods significantly abolished the neuroprotective effects of FGF5 against SCI. More importantly, serum FGF5 level was decreased in SCI patients, and elevated serum FGF5 level often indicate better prognosis. Our study identifies FGF5 as an effective therapeutic and prognostic target for SCI.


Sujet(s)
AMP-Activated Protein Kinases , Facteur de croissance fibroblastique de type 5 , Stress oxydatif , Traumatismes de la moelle épinière , Animaux , Humains , Souris , AMP-Activated Protein Kinases/métabolisme , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme , Moelle spinale/métabolisme , Traumatismes de la moelle épinière/métabolisme , Souris knockout , Mâle , Femelle , Adulte , Adulte d'âge moyen
5.
BMC Genomics ; 24(1): 298, 2023 Jun 02.
Article de Anglais | MEDLINE | ID: mdl-37268908

RÉSUMÉ

BACKGROUND: Rabbits are well-domesticated animals. As a crucial economic animal, rabbit has been successfully bred into wool-use, meat-use and fur-use breeds. Hair length is one of the most economically important traits affecting profitability in wool rabbits. In this study, to identify selection signatures with the long-hair trait, whole-genomic resequencing of long-haired rabbits (Angora rabbits) and short-haired rabbits (Rex and New Zealand rabbits) was performed. RESULTS: By genome-wide selective sweeping analysis based on population comparison, we identified a total of 5.85 Mb regions (containing 174 candidate genes) with strong selection signals. Six of these genes (Dusp1, Ihh, Fam134a, Map3k1, Spata16, and Fgf5) were enriched in the MAPK signalling and Hedgehog signalling pathways, both of which are closely associated with hair growth regulation. Among these genes, Fgf5 encodes the FGF5 protein, which is a well-established regulator of hair growth. There was a nonsynonymous nucleotide substitution (T19234C) in the Fgf5 gene. At this locus, the C allele was present in all of the tested Angora rabbits, while the T allele was dominant in New Zealand and Rex rabbits. We further confirmed that the C allele was conserved in Angora rabbits by screening an additional 135 rabbits. Moreover, the results of functional predictions and co-immunoprecipitation revealed that the T19234C mutation impaired the binding capacity of FGF5 to its receptor FGFR1. CONCLUSIONS: We discovered that the homozygous missense mutation T19234C within Fgf5 might contribute to the long-hair trait of Angora rabbits by reducing its receptor binding capacity. This finding will provide new insights into the genetic basis underlying the genetic improvement of Angora rabbits and benefit the improvement of rabbit breeding in the future.


Sujet(s)
Facteur de croissance fibroblastique de type 5 , Mutation faux-sens , Lapins , Animaux , Facteur de croissance fibroblastique de type 5/génétique , Protéines Hedgehog/génétique , Poils , Allèles
6.
DNA Cell Biol ; 42(3): 163-175, 2023 Mar.
Article de Anglais | MEDLINE | ID: mdl-36917699

RÉSUMÉ

Improving livestock and poultry growth rates and increasing meat production are urgently needed worldwide. Previously, we produced a myostatin (MSTN) and fibroblast growth factor 5 (FGF5) double-knockout (MF-/-) sheep by CRISPR Cas9 system to improve meat production, and also wool production. Both MF-/- sheep and the F1 generation (MF+/-) sheep showed an obvious "double-muscle" phenotype. In this study, we identified the expression profiles of long noncoding RNAs (lncRNAs) in wild-type and MF+/- sheep, then screened out the key candidate lncRNAs that can regulate myogenic differentiation and skeletal muscle development. These key candidate lncRNAs can serve as critical gatekeepers for muscle contraction, calcium ion transport and skeletal muscle cell differentiation, apoptosis, autophagy, and skeletal muscle inflammation, further revealing that lncRNAs play crucial roles in regulating muscle phenotype in MF+/- sheep. In conclusion, our newly identified lncRNAs may emerge as novel molecules for muscle development or muscle disease and provide a new reference for MSTN-mediated regulation of skeletal muscle development.


Sujet(s)
ARN long non codant , Animaux , Ovis/génétique , ARN long non codant/génétique , ARN long non codant/métabolisme , Myostatine/génétique , Myostatine/métabolisme , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme , Phénotype , Muscles squelettiques/métabolisme , Développement musculaire/génétique
7.
Biochem Genet ; 61(5): 1807-1826, 2023 Oct.
Article de Anglais | MEDLINE | ID: mdl-36808266

RÉSUMÉ

Circular RNAs (circRNAs) have been widely involved in the malignant development of human cancers. Circ_0001715 was aberrantly upregulated in non-small cell lung cancer (NSCLC). However, circ_0001715 function has never been researched. This study was designed to investigate the role and mechanism of circ_0001715 in NSCLC. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to examine the levels of circ_0001715, microRNA-1249-3p (miR-1249-3p) and Fibroblast Growth Factor 5 (FGF5). The proliferation detection was conducted using colony formation assay and EdU assay. Cell apoptosis was analyzed via flow cytometry. Wound healing assay and transwell assay were used for determination of migration and invasion, respectively. The protein levels were measured through western blot. Target analysis was carried out via dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Xenograft tumor model was established in mice for in vivo research. The significant upregulation of circ_0001715 was detected in NSCLC samples and cells. Circ_0001715 knockdown induced the inhibitory effects on proliferation, migration and invasion but the promoting effect on apoptosis of NSCLC cells. Circ_0001715 could interact with miR-1249-3p. The regulatory role of circ_0001715 was achieved by sponging miR-1249-3p. Furthermore, miR-1249-3p targeted FGF5 and miR-1249-3p acted as a cancer inhibitor by targeting FGF5. Moreover, circ_0001715 upregulated the FGF5 level via targeting miR-1249-3p. In vivo assay showed that circ_0001715 promoted the NSCLC progression through the miR-1249-3p/FGF5 axis. The current evidence elucidated that circ_0001715 served as an oncogenic regulator in NSCLC progression by depending on the miR-1249-3p/FGF5 axis.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Facteur de croissance fibroblastique de type 5 , Tumeurs du poumon , microARN , ARN circulaire , Animaux , Humains , Souris , Apoptose , Carcinome pulmonaire non à petites cellules/génétique , Lignée cellulaire tumorale , Prolifération cellulaire , Modèles animaux de maladie humaine , Facteur de croissance fibroblastique de type 5/génétique , Tumeurs du poumon/génétique , microARN/génétique , ARN circulaire/génétique
8.
J Endovasc Ther ; 30(6): 937-950, 2023 12.
Article de Anglais | MEDLINE | ID: mdl-35880306

RÉSUMÉ

PURPOSE: LncRNA-Atherosclerotic plaque pathogenesis-associated transcript (APPAT) could be detected in circulating blood and has been demonstrated to correlate with the development of atherosclerosis in our previous work. It could be a potential noninvasive biomarker for earlier diagnoses of clinical cardiovascular disease. Moreover, the expression of miR-647 increased in ox-LDL-treated vascular smooth muscle cells and peripheral blood of patients with coronary heart disease. A negative correlation between APPAT and miR-647 was confirmed, and FGF5 was screened as molecular target of miR-647. However, it is largely unclear how APPAT, miR-647, and FGF5 interact and function in disease development. Here, we aim to explore the underlying molecular mechanism in this progression. MATERIALS AND METHODS: APPAT, miR-647, and FGF5 expression levels were detected by quantitative reverse transcription polymerase chain reaction; cell proliferation was detected by EdU incorporation assay; cell migration was detected by wound-healing assay; the molecular interaction of APPAT/FGF5 with miR-647 was verified by dual-luciferase reporter assay; the western blot was performed to determine the gene expression at protein levels; subcellular localizations of APPAT and miR-647 were observed by fluorescence in situ hybridization; cytosolic and nucleus fractionation assay was performed to further detect the distribution of miR-647. RESULTS: APPAT and miR-647 have inverse effects on human aortic smooth muscle cells' (HASMCs) proliferation and migration. APPAT negatively regulated the cell activity, whereas miR-647 did it in a positive way (p<0.05). Three pairs of molecular interplay were found: mutual negative regulation between APPAT and miR-647, APPAT downregulated FGF5, miR-647 regulation on FGF5 (p<0.05). Subcellular location assay confirmed the molecular interaction of APPAT and miR-647. CONCLUSIONS: APPAT could suppress the migration and proliferation of ox-LDL-treated HASMCs via interacting with miR-647 and FGF5. We revealed a nontypical competing endogenous RNA mechanism of long noncoding RNA in the progression of atherosclerosis.


Sujet(s)
Athérosclérose , microARN , Humains , microARN/génétique , microARN/métabolisme , Hybridation fluorescente in situ , Résultat thérapeutique , Athérosclérose/génétique , Prolifération cellulaire/génétique , Myocytes du muscle lisse/métabolisme , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme
9.
Int J Mol Sci ; 23(19)2022 Oct 06.
Article de Anglais | MEDLINE | ID: mdl-36233155

RÉSUMÉ

Fibroblast growth factor 5 (FGF5) is an important molecule required for the transition from anagen to catagen phase of the mammalian hair cycle. We previously reported that Syrian hamsters harboring a 1-bp deletion in the Fgf5 gene exhibit excessive hair growth in males. Herein, we generated Fgf5 mutant mice using genome editing via oviductal nucleic acid delivery (GONAD)/improved GONAD (i-GONAD), an in vivo genome editing system used to target early embryos present in the oviductal lumen, to study gender differences in hair length in mutant mice. The two lines (Fgf5go-malc), one with a 2-bp deletion (c.552_553del) and the other with a 1-bp insertion (c.552_553insA) in exon 3 of Fgf5, were successfully established. Each mutation was predicted to disrupt a part of the FGF domain through frameshift mutation (p.Glu184ValfsX128 or p.Glu184ArgfsX128). Fgf5go-malc1 mice had heterogeneously distributed longer hairs than wild-type mice (C57BL/6J). Notably, this change was more evident in males than in females (p < 0.0001). Immunohistochemical analysis revealed the presence of FGF5 protein in the dermal papilla and outer root sheath of the hair follicles from C57BL/6J and Fgf5go-malc1 mice. Histological analysis revealed that the prolonged anagen phase might be the cause of accelerated hair growth in Fgf5go-malc1 mice.


Sujet(s)
Facteur de croissance fibroblastique de type 5 , Poils , Caractères sexuels , Animaux , Femelle , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme , Poils/croissance et développement , Follicule pileux/métabolisme , Mâle , Souris , Souris de lignée C57BL , Mutation , Acides nucléiques/métabolisme , Facteurs sexuels
10.
Oncol Rep ; 48(3)2022 Sep.
Article de Anglais | MEDLINE | ID: mdl-35866594

RÉSUMÉ

The present study aimed to identify the function of miR­491­3p in regulating non­small cell lung cancer (NSCLC). Tumor tissues and adjacent normal tissues were collected from 43 patients with NSCLC. A549 and H1299 cells were transfected with microRNA (miR)­491­3p mimic, mimic negative control (NC), miR­491­3p inhibitor, inhibitor NC, pcDNA3.1­FGF5 vector and control vector. Cell counting kit­8 assay and Edu experiments were performed to assess cell viability and proliferation. Matrigel experiment, wound healing assay and flow cytometric analysis were performed to explore cell invasion, migration and apoptosis, respectively. A dual­luciferase reporter experiment was performed to identify the relationship between miR­491­3p and fibroblast growth factor 5 (FGF5). In vivo study was conducted by using nude mice. The miR­491­3p and FGF5 protein expression levels were investigated using reverse transcription­quantitative polymerase chain reaction and western blot analysis. In NSCLC tumor tissues, miR­491­3p was downregulated and FGF5 was upregulated (P<0.01). Low miR­491­3p expression and high FGF5 mRNA expression was associated with poor outcomes in patients, including advanced TNM stage and lymph node metastasis (P<0.05). upregulation of miR­491­3p suppressed viability, proliferation, invasion and migration of NSCLC cells; however, it promoted apoptosis (P<0.01). FGF5 was a target gene for miR­491­3p. miR­491­3p directly inhibited FGF5 expression. upregulation of FGF5 significantly reversed the inhibitory effects of miR­491­3p on malignant phenotypes of NSCLC cells (P<0.01). miR­491­3p overexpression suppressed the in vivo growth of NSCLC. Thus, it was identified that miR­491­3p functions as a tumor suppressor in NSCLC by directly targeting FGF5.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Facteur de croissance fibroblastique de type 5 , Tumeurs du poumon , microARN , Cellules A549 , Animaux , Carcinome pulmonaire non à petites cellules/anatomopathologie , Lignée cellulaire tumorale , Mouvement cellulaire/génétique , Prolifération cellulaire/génétique , Facteur de croissance fibroblastique de type 5/génétique , Régulation de l'expression des gènes tumoraux , Humains , Tumeurs du poumon/anatomopathologie , Souris , Souris nude , microARN/génétique
11.
Mol Genet Genomics ; 297(3): 791-800, 2022 May.
Article de Anglais | MEDLINE | ID: mdl-35380267

RÉSUMÉ

Fibroblast growth factor 5 (FGF5), which is a well-established causative factor for blood pressure, has been identified as a susceptibility gene for preeclampsia (PE) in European and Central Asian women. Here, we examined whether polymorphism rs16998073 in FGF5 confer a significant risk to PE in Chinese Han population by case-control association analysis. FGF5 rs16998073 was genotyped by Sanger sequencing in women with preeclampsia (n = 187) and healthy controls (n = 229) of Han Chinese. We found the frequency of rs16998073T allele was significantly higher in PE patients than that in controls. Next, we utilized dual-luciferase reporter assays and electrophoretic mobility shift assay (EMSA) reactions to investigate whether rs16998073 different alleles could affect the transcriptional activity of FGF5. The dual luciferase reporter assay showed that T allele increased the transcriptional efficiency by 1.5-fold compared with the G allele. Similarly, EMSA revealed that the T allele had a strong transcription factor binding strength compared with the G allele. We then examined the mRNA and protein expression levels of FGF5 in placental tissues by real-time PCR and Western blot assays. We found FGF5 were significantly upregulated in placental tissues from PE patients or PE mouse model than their corresponding controls. In addition, in vitro cell experiments confirmed that FGF5 could promote cell apoptosis of HTR8/SVneo and inhibit cell invasion. Taken together, our data provide evidence implicating rs16998073 of FGF5 as a functional genetic risk variant for PE disease and FGF5 might participate in development of PE disease.


Sujet(s)
Prédisposition génétique à une maladie , Pré-éclampsie , Animaux , Études cas-témoins , Chine/épidémiologie , Femelle , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme , Humains , Souris , Placenta/métabolisme , Polymorphisme de nucléotide simple/génétique , Pré-éclampsie/génétique , Pré-éclampsie/métabolisme , Grossesse
12.
Int J Biol Markers ; 37(2): 178-190, 2022 Jun.
Article de Anglais | MEDLINE | ID: mdl-35341378

RÉSUMÉ

BACKGROUND: Triple-negative breast cancer (TNBC) is a subtype of breast cancers with a high recurrence and mortality. The important factors promoting the TNBC process have not been fully identified. In this research, the role of a TNBC-related circular RNA (circRNA), circ_0041732, was revealed in TNBC cell tumor properties. METHODS: The expression levels of circ_0041732, microRNA-149-5p (miR-149-5p) and fibroblast growth factor 5 (FGF5) were detected by quantitative real-time polymerase chain reaction. The protein expression was determined by Western blot analysis or immunohistochemistry assay. Cell proliferation was detected by cell counting kit-8 and cell colony formation assays. Cell apoptosis was analyzed by flow cytometry and caspase-3 activity assays. Cell migration and invasion were evaluated by wound-healing and transwell invasion assays. Cell angiogenic capacity was investigated by a tube formation assay. The targeting relationship between miR-149-5p and circ_0041732 or FGF5 was identified by dual-luciferase reporter and RNA immunoprecipitation assays. The impacts of circ_0041732 knockdown on tumor formation were determined by an in vivo assay. RESULTS: Circ_0041732 and FGF5 expression were significantly upregulated, whereas miR-149-5p was downregulated in TNBC tissues and cells compared with normal breast tissues and cells, respectively. Circ_0041732 silencing inhibited TNBC cell proliferation, migration, invasion, and tube formation, but induced apoptosis. Additionally, circ_0041732 regulated TNBC cell tumor properties by binding to miR-149-5p. MiR-149-5p also modulated TNBC cell tumor properties by targeting FGF5. Furthermore, circ_0041732 knockdown hindered tumor formation in vivo. CONCLUSION: Circ_0041732 silencing suppressed TNBC cell tumor properties by decreasing FGF5 expression through miR-149-5p. This finding demonstrated that circ_0041732 had the potential as a therapeutic target for TNBC.


Sujet(s)
microARN , Tumeurs du sein triple-négatives , Prolifération cellulaire/génétique , Facteur de croissance fibroblastique de type 5/génétique , Facteur de croissance fibroblastique de type 5/métabolisme , Régulation de l'expression des gènes tumoraux , Humains , microARN/génétique , microARN/métabolisme , ARN circulaire/génétique , Tumeurs du sein triple-négatives/génétique , Tumeurs du sein triple-négatives/anatomopathologie
13.
Medicine (Baltimore) ; 101(5): e28703, 2022 Feb 04.
Article de Anglais | MEDLINE | ID: mdl-35119014

RÉSUMÉ

ABSTRACT: Genetic variation is known to affect response to calcium channel blockers (CCBs) among different populations. This study aimed to determine the genetic variations associated with poor response to this class of antihypertensive drugs among Filipinos.One hundred eighty one hypertensive participants on CCBs therapy were included in an unmatched case-control study. Genomic deoxyribonucleic acid were extracted and genotyped for selected genetic variants. Regression analysis was used to determine the association of genetic and clinical variables with poor response to medication.The variant rs1458038 near fibroblast growth factor 5 gene showed significant association with poor blood pressure-lowering response based on additive effect (CT genotype: adjusted OR 3.41, P = .001; TT genotype: adjusted OR 6.72, P < .001).These findings suggest that blood pressure response to calcium channels blockers among Filipinos with hypertension is associated with gene variant rs1458038 near fibroblast growth factor 5 gene. Further studies are recommended to validate such relationship of the variant to the CCB response.


Sujet(s)
Antihypertenseurs , Inhibiteurs des canaux calciques , Facteur de croissance fibroblastique de type 5/génétique , Hypertension artérielle , Antihypertenseurs/usage thérapeutique , Pression sanguine/effets des médicaments et des substances chimiques , Inhibiteurs des canaux calciques/usage thérapeutique , Études cas-témoins , Humains , Hypertension artérielle/traitement médicamenteux , Hypertension artérielle/génétique , Philippines
14.
Genes (Basel) ; 13(1)2022 01 01.
Article de Anglais | MEDLINE | ID: mdl-35052442

RÉSUMÉ

Genetic analysis of the hair-length of Sapsaree dogs, a Korean native dog breed, showed a dominant mode of inheritance for long hair. Genome-Wide Association Study (GWAS) analysis and subsequent Mendelian segregation analysis revealed an association between OXR1, RSPO2, and PKHD1L1 on chromosome 13 (CFA13). We identified the previously reported 167 bp insertion in RSPO2 3' untranslated region as a causative mutation for hair length variations. The analysis of 118 dog breeds and wolves revealed the selection signature on CFA13 in long-haired breeds. Haplotype analysis showed the association of only a few specific haplotypes to the breeds carrying the 167 bp insertion. The genetic diversity in the neighboring region linked to the insertion was higher in Sapsarees than in other Asian and European dog breeds carrying the same variation, suggesting an older history of its insertion in the Sapsaree genome than in that of the other breeds analyzed in this study. Our results show that the RSPO2 3' UTR insertion is responsible for not only the furnishing phenotype but also determining the hair length of the entire body depending on the genetic background, suggesting an epistatic interaction between FGF5 and RSPO2 influencing the hair-length phenotype in dogs.


Sujet(s)
Épistasie , Facteur de croissance fibroblastique de type 5/génétique , Poils/croissance et développement , Thrombospondines/génétique , Animaux , Chiens , Poils/métabolisme
15.
Hum Genet ; 140(11): 1517-1523, 2021 Nov.
Article de Anglais | MEDLINE | ID: mdl-34599367

RÉSUMÉ

Hair length can be a highly variable trait within the Felis catus species, varying between and within different cat breeds. Previous research has demonstrated this variability is due to recessive mutations within the fibroblast growth factor 5 (FGF5) gene. Following a genetic screen, four longhaired Maine Coons were identified that had only one copy of a known FGF5 mutation. We performed DNA sequencing on samples from two of these Maine Coons and identified a missense mutation in FGF5 c.577G > A p.Ala193Thr. Genetic screening via restriction digest was then performed on samples from the other two Maine Coons and an additional 273 cats of various breeds. This screening found that only the two additional Maine Coons were heterozygous for the novel variant. Furthermore, the novel variant was not identified after in silico analysis of 68 whole genome cat sequences from various breeds, demonstrating that this novel mutation is most likely a breed-specific variant for the Maine Coon, contributing to the longhair phenotype in about 3% of these cats.


Sujet(s)
Fourrure animale/anatomie et histologie , Chats/génétique , Facteur de croissance fibroblastique de type 5/génétique , Mutation faux-sens , Animaux , Chats/anatomie et histologie , Femelle , Facteur de croissance fibroblastique de type 5/composition chimique , Hétérozygote , Mâle , Pedigree
17.
Anim Genet ; 52(6): 848-856, 2021 Dec.
Article de Anglais | MEDLINE | ID: mdl-34432312

RÉSUMÉ

Several FGF5 mutations are associated with hair length variation in many domestic animals, including New World camelids. The dromedary was investigated in the present study with breeds exhibiting marked variations in hair length. This study aimed to: (1) identify the molecular variation(s) in the three exons of FGF5 of a diverse group of breeds (Mejaheem, Shaele, Sofor, Waddah and Omani; n = 28); (2) examine the association of the identified variants with hair length; (3) validate the association via genotyping the polymorphism in a large population of diverse camels (n = 113); and (4) test the segregation of the identified variant with hair length in a pedigree. A non-synonymous mutation (c.779 C > T) was identified that changes the amino acid from proline to leucine and was found to be associated with different hair length in dromedaries. The variants at c.779 displayed a co-dominance mode of inheritance and three hair length phenotypes: short (C/C), intermediate (C/T) and long (T/T). Across the examined dromedary breeds, both alleles were present, which is probably due to the breeders' preference for an intermediate hair length. When compared with other camelids, the identified variant was found exclusively in dromedaries with the ancestral allele at c.779 being 'C'. This study constitutes the first thorough exploration of the FGF5 gene in dromedaries.


Sujet(s)
Chameaux/génétique , Facteur de croissance fibroblastique de type 5/génétique , Poils/croissance et développement , Mutation faux-sens , Animaux , Chameaux/croissance et développement , Facteur de croissance fibroblastique de type 5/métabolisme
18.
Int J Biol Sci ; 17(4): 1026-1040, 2021.
Article de Anglais | MEDLINE | ID: mdl-33867826

RÉSUMÉ

Cashmere is a rare and specialised animal fibre, which grows on the outer skin of goats. Owing its low yield and soft, light, and warm properties, it has a high economic value. Here, we attempted to improve existing cashmere goat breeds by simultaneously increasing their fibre length and cashmere yield. We attempted this by knocking in the vascular endothelial growth factor (VEGF) at the fibroblast growth factor 5(FGF5) site using a gene editing technology and then studying its hair growth-promoting mechanisms. We show that a combination of RS-1 and NU7441 significantly improve the efficiency of CRISPR/Cas9-mediated, homologous-directed repair without affecting the embryo cleavage rate or the percentages of embryos at different stages. In addition, we obtained a cashmere goat, which integrated the VEGF gene at the FGF5 site, and the cashmere yield and fibre length of this gene-edited goat were improved. Through next-generation sequencing, we found that the up-regulation of VEGF and the down-regulation of FGF5 affected the cell cycle, proliferation, and vascular tone through the PI3K-AKT signalling pathway and at extracellular matrix-receptor interactions. Owing to this, the gene-edited cashmere goat showed impressive cashmere performance. Overall, in this study, we generated a gene-edited cashmere goat by integrating VEGF at the FGF5 site and provided an animal model for follow-up research on hair growth mechanisms.


Sujet(s)
Fourrure animale/croissance et développement , Facteur de croissance fibroblastique de type 5/génétique , Techniques de knock-in de gènes , Capra/génétique , Techniques de transfert nucléaire , Facteur de croissance endothéliale vasculaire de type A/génétique , Animaux , Systèmes CRISPR-Cas , Cellules cultivées , Capra/métabolisme , Peau/métabolisme , Textiles , Transcriptome
19.
Eur Rev Med Pharmacol Sci ; 25(4): 1959-1966, 2021 02.
Article de Anglais | MEDLINE | ID: mdl-33660806

RÉSUMÉ

OBJECTIVE: To elucidate the role of TUG1 in the onset of type 2 diabetes mellitus (T2DM) and the potential mechanism. MATERIALS AND METHODS: Relative levels of TUG1 and SP1 in high-fat diet animal model and high-glucose cell model were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR), and their correlation was analyzed. Potential binding sites in the promoter sequences of TUG1 and SP1 were predicted using the JASPAR. Their interaction was further confirmed by chromatin immunoprecipitation (ChIP) and Dual-Luciferase reporter assay. The influences of TUG1 on proliferative and apoptotic potentials in Min6 cells were examined by Cell Counting Kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EdU) assay and flow cytometry, respectively. Subsequently, the interaction in the TUG1/miR-188-3p /FGF5 axis was similarly explored by Dual-Luciferase reporter assay. RESULTS: SP1 and TUG1 were downregulated in high-fat and high-glucose models, and they displayed a positive correlation. TUG1 bound E2 region in SP1 promoters. Knockdown of TUG1 inhibited proliferative rate and induced apoptosis in high-glucose-treated Min6 cells. Furthermore, the TUG1 / miR-188-3p /FGF5 axis was identified to be responsible for regulating Min6 cell functions. CONCLUSIONS: SP1 induces TUG1 downregulation in T2DM cell models, which further regulates proliferative and apoptotic potentials in islet cells by activating the miR-188-3p/FGF5 axis.


Sujet(s)
Apoptose , Diabète expérimental/métabolisme , Diabète de type 2/métabolisme , Facteur de croissance fibroblastique de type 5/métabolisme , Ilots pancréatiques/métabolisme , microARN/métabolisme , ARN long non codant/métabolisme , Facteur de transcription Sp1/métabolisme , Animaux , Prolifération cellulaire , Cellules cultivées , Diabète expérimental/anatomopathologie , Diabète de type 2/anatomopathologie , Facteur de croissance fibroblastique de type 5/génétique , Ilots pancréatiques/anatomopathologie , Souris , microARN/génétique , ARN long non codant/génétique , Facteur de transcription Sp1/génétique
20.
Mol Cell ; 81(5): 969-982.e13, 2021 03 04.
Article de Anglais | MEDLINE | ID: mdl-33482114

RÉSUMÉ

Many genes are regulated by multiple enhancers that often simultaneously activate their target gene. However, how individual enhancers collaborate to activate transcription is not well understood. Here, we dissect the functions and interdependencies of five enhancer elements that together activate Fgf5 expression during exit from naive murine pluripotency. Four intergenic elements form a super-enhancer, and most of the elements contribute to Fgf5 induction at distinct time points. A fifth, poised enhancer located in the first intron contributes to Fgf5 expression at every time point by amplifying overall Fgf5 expression levels. Despite low individual enhancer activity, together these elements strongly induce Fgf5 expression in a super-additive fashion that involves strong accumulation of RNA polymerase II at the intronic enhancer. Finally, we observe a strong anti-correlation between RNA polymerase II levels at enhancers and their distance to the closest promoter, and we identify candidate elements with properties similar to the intronic enhancer.


Sujet(s)
Éléments activateurs (génétique) , Facteur de croissance fibroblastique de type 5/génétique , Régulation de l'expression des gènes au cours du développement , Cellules souches embryonnaires de souris/métabolisme , Régions promotrices (génétique) , RNA polymerase II/génétique , Animaux , Lignée cellulaire , Noyau de la cellule/génétique , Noyau de la cellule/métabolisme , Drosophila melanogaster/génétique , Drosophila melanogaster/métabolisme , Exons , Facteur de croissance fibroblastique de type 5/métabolisme , Techniques de knock-out de gènes , Gènes rapporteurs , Protéines à fluorescence verte/génétique , Protéines à fluorescence verte/métabolisme , Histone/génétique , Histone/métabolisme , Introns , Protéines luminescentes/génétique , Protéines luminescentes/métabolisme , Souris , Cellules souches embryonnaires de souris/cytologie , RNA polymerase II/métabolisme , Analyse de séquence d'ARN , Transduction du signal , Analyse sur cellule unique , Transcription génétique ,
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE